FindTrial
Sign In

Concomitant tricuspid valve surgery in left ventricular assist device implantation

Impact of concomitant tricuspid valve surgery during left ventricular assist device implantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053440
Enrollment
Unknown
Registered
2021-11-21
Start date
2021-11-30
Completion date
Unknown
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage heart failure

Interventions

Tricuspid valve surgery group:Concurrent tricuspid valve surgery during LVAD implantation
Non-tricuspid valve surgery group:no tricuspid valve surgery was performed during LVAD implantation

Sponsors

University Hospital Muenster
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 99 Years

Inclusion criteria

Inclusion criteria: All adult patients who received CF-LVAD implantation in our institution were retrieved, patients were diagnosed as moderate-to-severe TR.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of LVAD implantation; 2. Patients undergoing LVAD revision; 3. Patients who received heart transplantation before LVAD implantation; 4. Patients receiving BiVAD support; 5. Patients without moderate to severe TR as determined by echocardiography.

Design outcomes

Primary

MeasureTime frame
Mortality;Right heart failure;acute kidney injury;—

Countries

China

Contacts

Public ContactTie Hongtao

Münster University Hospital and the First Affiliated Hospital of Chongqing Medical University

ht_tie@hospital.cqmu.edu.cn+86 491 628713419

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026